Everolimus

Active ingredient

Everolimus

Therapeutic group

Antineoplastic agent, protein kinase inhibitor

Pharmaceutical form

Tablets

Strengh

2,5 mg / 5 mg / 10 mg

Reference product

Afinitor

BIOEQUIVALENCE

Yes (EU)

Our generics are developed and manufactured under European quality standards

Ready to meet our team?

Basic information on data protection

In accordance with the Organic Law 3/2018, of December 5, on the Protection of Personal Data and Guarantee of Digital Rights and Regulation (EU) 2016/679 on the protection of natural persons with regard to the processing of personal data and the free movement of such data, TAMARANG, S.A. informs you that your data will be incorporated into a register of processing activities of which it is Responsible for the purpose of handling your request and sending you the requested information.

You have the right to access, rectify, restrict, oppose, carry and delete the data, as well as other rights, indicated in the additional information, which can be exercised by contacting the postal address of the responsible party indicated below or by sending an e-mail to dpo@fhrt.com. You can consult additional and detailed information about the treatment of your data in the Privacy Policy or by requesting it to C/Balmes, 85, 2nd Floor – 08008 – Barcelona.